FMC
Live chart
What they do
FMC Corporation, an agricultural sciences company, develops, markets, and sells crop protection chemicals in Latin America, North America, Europe, the Middle East, Africa, and Asia. The company offers crop protection chemicals, including insecticides, herbicides, and fungicides. It also provides biologicals, crop nutrition, and seed treatment products.
For information only · Important disclosures
Grades vs sector
Momentum4th percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
Growth1st percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
Value58th percentile in sectorB-
Percentile within its GICS sector across the S&P 1500.
Profitability3rd percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Discounted cash flow
Edit assumptions · recalculates instantly
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.46 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Materials
cheaper
cheaper
cheaper
Forward EPS $1.39 vs trailing $-21.46. Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Piotroski F-score 1/9 · last two fiscal years
Analysts
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $3.5B | $-2.2B | – |
| 2024 | $4.2B | $341.1M | – |
| 2023 | $4.5B | $1.3B | – |
| 2022 | $5.8B | $736.5M | – |
| 2021 | $5.0B | $739.6M | – |
| 2020 | $4.6B | $552.4M | – |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -15.8%.
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-07-29 | 0.22 | 0.26 | +17.0% |
| 2026-04-29 | -0.38 | -0.23 | +39.6% |
| 2026-02-04 | 1.20 | 1.20 | -0.2% |
| 2025-10-29 | 0.85 | 0.89 | +4.1% |
| 2025-07-30 | 0.62 | 0.69 | +11.2% |
| 2025-04-30 | 0.09 | 0.18 | +94.7% |
| 2025-02-04 | 1.60 | 1.79 | +11.6% |
| 2024-10-29 | 0.53 | 0.69 | +30.3% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $867.1M | -17.5% |
| 2026-03-31 | $758.6M | – |
| 2025-12-31 | $1.1B | – |
| 2025-09-30 | $542.2M | – |
| 2025-06-30 | $1.1B | – |
Analyst actions
PT $6
PT $4
PT $8
PT $5
PT $9
PT $12
Recent dividends
Insider trades
$16.0K
–
–
–
–
–
–
–
–
–
–
Stats refreshed 2026-10-21 12:05:58 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app
Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.
Beta 0.9 · Oct 21, 2026